An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).
University of Saskatchewan (USask) researchers have demonstrated that it is possible to “train” microscopic black fungi in the lab to find radiation sources—a discovery with potential applications such as cleaning up radioactive waste from nuclear accidents and detecting radioactive fallout from illicit nuclear testing.
From the discovery of an enzyme able to turn any blood into a universal donor type, to a process that creates plastic from sunshine and pollution, to identifying heat-tolerance traits in pea varieties, scientific advances achieved at the Canadian Light Source at the University of Saskatchewan (USask) are being celebrated as the institution marks the 20th anniversary of its launch.
A University of Saskatchewan medical research team will receive $987,000 from Western Economic Diversification (WD) towards a $4.55-million project aimed at producing and testing new imaging agents for diagnosing lung and colorectal cancers in humans.
At the opening of the new Innovation Wing of the Saskatchewan Centre for Cyclotron Sciences (SCCS) on Wednesday, May 22, Tina Beaudry-Mellor, Minister Responsible for Innovation Saskatchewan, announced $11.6 million in new funding over the next five years for the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (Fedoruk Centre) at the University of Saskatchewan (USask).
A University of Saskatchewan (USask) researcher has been recognized as one of 30 rising stars worldwide in the field of nuclear medicine and molecular imaging.
A novel treatment for advanced colorectal cancer—using a radioactive antibody that attaches to cancer cells and kills them—is being developed by researchers at the University of Saskatchewan’s (USask) College of Medicine.
SASKATOON – A University of Saskatchewan (USask) medical research team has made a ground-breaking finding with potential to lead to more effective, longer-lasting and better-tolerated treatments for cystic fibrosis (CF).
Teenagers and pet dogs stand to benefit from a novel therapy for bone cancer being developed at the University of Saskatchewan (USask).
With $3.6 million in new funding, the Saskatchewan Centre for Cyclotron Sciences (SCCS) at the University of Saskatchewan will renovate and equip its Innovation Wing to conduct leading-edge imaging research that will improve detection of cancers and other diseases, and advance human, animal and plant health.
More than 25,000 women in Canada are diagnosed every year with breast cancer, with no specific therapy available to target the most aggressive sub-type called triple-negative breast cancer (TNBC).
An estimated 55,000 Canadians over age 18 have been diagnosed with Parkinson’s disease, characterized by symptoms such as tremors, muscle rigidity and unstable balance.
A University of Saskatchewan research team has established a national consortium with the University of Toronto to produce synthetic antibodies for diagnosing and fighting cancer and other diseases.
Traditional cancer treatment tablets and injections deliver cancer-killing drugs indiscriminately to all parts of the body, often causing serious side effects.
